Related Experiment Videos
Treatment of disseminated intravascular coagulation
1Division of Hematology, University of Southern California School of Medicine, Norris Cancer Hospital & Research Institute, Los Angeles 90033.
Insights
Treating disseminated intravascular coagulation (DIC) is complex due to varied causes and manifestations. Continued clinical studies are crucial for effective management strategies in specific patient groups.
Area of Science:
- Hematology
- Critical Care Medicine
Background:
- Disseminated intravascular coagulation (DIC) is a complex condition complicating numerous disorders with diverse clinical presentations.
- Current management strategies for DIC lack robust evidence from well-controlled studies in homogeneous patient groups, leading to ongoing controversy.
Purpose of the Study:
- To highlight the complexity and controversial nature of disseminated intravascular coagulation (DIC) treatment.
- To emphasize the importance of continued clinical and laboratory observations for understanding DIC's natural history and evaluating therapeutic interventions.
Main Methods:
- Review of existing literature and clinical observations regarding the management of disseminated intravascular coagulation (DIC).
- Analysis of the challenges in conducting well-controlled studies for relatively homogeneous patient groups with DIC.
Main Results:
- Treatment for DIC remains controversial due to its varied associations and lack of definitive evidence from controlled trials.
- Clinical and laboratory data from carefully observed patient groups are essential for clarifying the effects of DIC and the efficacy of treatments.
Conclusions:
- Accumulating careful clinical studies in specific patient populations is vital for establishing optimal DIC management protocols.
- Further research is needed to address the complexities of DIC treatment and provide evidence-based guidelines for individual patient care.
Abstract:
The treatment of DIC is extremely complex, stemming from the fact that it complicates many different disorders and may have a variety of clinical manifestations. In addition, there continues to be a lack of well-controlled studies regarding various methods of management in relatively homogeneous groups of patients. Therefore treatment continues to be controversial and probably will remain so in the near future. However, it is clear that any careful clinical and laboratory observations in groups of patients with the same underlying disorder are extremely helpful in elucidating the natural history of the process, in determining its effect on the patient, and clarifying whether certain therapeutic interventions may be helpful. Therefore the continued accumulation of careful clinical studies will help in determining the proper management of DIC in patients with the same underlying disorder and in given individual situations.